Protein: CITE2
Cbp/p300-interacting transactivator 2 (MSG-related protein 1) (MRG-1) (P35srj)

Gene: CITE2, CITED2
Organism: Homo sapiens
Interactions: 19
UniProt ID: Q99967

Gene Ontology (top 5):
GO:0000122 - negative regulation of transcription by RNA polymerase II
GO:0000785 - chromatin
GO:0001570 - vasculogenesis
GO:0001666 - response to hypoxia
GO:0001829 - trophectodermal cell differentiation

Download interactions: TXT   MITAB-2.5

Interaction Interactor Experiments Homologs Category Interaction
Score
Confidence

999025

EP300
Histone acetyltransferase p300

9

4

Small-scale

0.975

High

403685

AP2A
Transcription factor AP-2-alpha

2

4

Small-scale

0.625

High

1270263

AP2C
Transcription factor AP-2 gamma

2

4

Small-scale

0.625

High

1270778

CBP
CREB-binding protein

1

4

Small-scale

0.618

High

1265989

AP2B
Transcription factor AP-2-beta

2

4

Small-scale

0.595

High

839814

LHX2
LIM/homeobox protein Lhx2

1

1

Small-scale

0.573

High

950265

SMAD3
Mothers against decapentaplegic homolog 3

1

2

Small-scale

0.561

High

1307480

FBXL5
F-box/LRR-repeat protein 5

1

0

Small-scale

0.520

High

782643

HNF4A
Hepatocyte nuclear factor 4-alpha

1

1

Small-scale

0.506

High

281848

WFS1
Wolframin

1

0

High-throughput

0.493

High

893464

PRPS1
Ribose-phosphate pyrophosphokinase 1

1

0

High-throughput

0.493

High

1307479

LHX3
LIM/homeobox protein Lhx3

1

1

Small-scale

0.481

High

589915

TBP
TATA-box-binding protein

1

0

Small-scale

0.480

High

659035

MK01
Mitogen-activated protein kinase 1

1

0

Small-scale

0.480

High

1078642

SMAD2
Mothers against decapentaplegic homolog 2

1

2

Small-scale

0.479

High

1307478

EGLN3
Prolyl hydroxylase EGLN3

1

1

High-throughput

0.479

High

941361

RNF4
E3 ubiquitin-protein ligase RNF4

1

0

High-throughput

0.458

High

238908

TPST2
Protein-tyrosine sulfotransferase 2

1

0

High-throughput

0.279

Low

660684

GRN
Progranulin

1

0

High-throughput

0.268

Low


Service provided by Combinatics, Japan

Last updated: 15 Jul 2024